Markets for GvHD in five APAC markets to grow at 8.2 per cent CAGR in 10 years: GlobalData EP News Bureau Aug 27, 2020 The impact of approved therapies replacing generic off-label treatments will be the main driver of growth in the 5GM GvHD market
Takeda launches IBD medication Kynteles in India EP News Bureau Jul 8, 2020 Used to treat ulcerative colitis and Crohn's Disease as well, the drug expands the company’s GI portfolio in the country
